We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
Cap. Flow
-$2.32B
Cap. Flow %
-5.5%
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236

Sector Composition

Rank Sector Weight
1 Technology 14.48%
2 Financials 12.95%
3 Healthcare 12.03%
4 Industrials 10.73%
5 Consumer Discretionary 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
126
LyondellBasell Industries
LYB
$18.8B
$74.9M 0.18%
679,084
+30,527
+5% +$3.17M
CA
127
DELISTED
CA, Inc.
CA
$74.5M 0.18%
2,238,225
+361,631
+19% +$12M
FISV
128
Fiserv Inc
FISV
$28.9B
$74.3M 0.18%
1,133,494
+10,564
+0.9% +$682K
SCHW
129
Charles Schwab
SCHW
$184B
$74.1M 0.18%
1,442,454
-247,256
-15% -$11.6M
URI icon
130
United Rentals
URI
$67.9B
$74.1M 0.18%
430,930
+26,035
+6% +$3.96M
SPGI icon
131
S&P Global
SPGI
$125B
$73.9M 0.18%
436,342
-5,076
-1% -$829K
EW icon
132
Edwards Lifesciences
EW
$48.2B
$73.5M 0.17%
1,957,623
+266,793
+16% +$9.79M
TAP icon
133
Molson Coors Class B
TAP
$7.97B
$73.5M 0.17%
895,874
+310,780
+53% +$25.1M
ALXN
134
DELISTED
Alexion Pharmaceuticals
ALXN
$73.5M 0.17%
614,643
+166,839
+37% +$20.3M
APH icon
135
Amphenol
APH
$177B
$73.4M 0.17%
3,341,828
-270,048
-7% -$5.94M
CSRA
136
DELISTED
CSRA Inc.
CSRA
$73.3M 0.17%
2,451,374
+402,315
+20% +$12.2M
CAH icon
137
Cardinal Health
CAH
$54.5B
$73.2M 0.17%
1,195,410
+316,772
+36% +$19.6M
SJM icon
138
J.M. Smucker
SJM
$13.2B
$73.1M 0.17%
588,674
+56,718
+11% +$6.3M
NTAP icon
139
NetApp
NTAP
$34.2B
$73.1M 0.17%
1,321,321
-91,544
-6% -$4.59M
MCK icon
140
McKesson
MCK
$104B
$72.7M 0.17%
465,969
+37,177
+9% +$5.51M
HPQ icon
141
HP
HPQ
$25.9B
$72.5M 0.17%
3,452,986
-323,536
-9% -$6.88M
AES icon
142
AES
AES
$10.6B
$72.5M 0.17%
6,695,202
+1,185,282
+22% +$12.8M
LUMN icon
143
Lumen
LUMN
$6.38B
$72.5M 0.17%
4,344,086
+1,494,802
+52% +$25.3M
IT icon
144
Gartner
IT
$10.4B
$72.4M 0.17%
587,518
+61,064
+12% +$7.42M
KEY icon
145
KeyCorp
KEY
$24.3B
$72.3M 0.17%
3,586,746
-50,895
-1% -$960K
MDT icon
146
Medtronic
MDT
$111B
$72.3M 0.17%
894,952
+66,060
+8% +$5.29M
ADP icon
147
Automatic Data Processing
ADP
$106B
$72.1M 0.17%
615,646
+33,570
+6% +$3.84M
CSX icon
148
CSX Corp
CSX
$94.2B
$72.1M 0.17%
3,931,941
+715,944
+22% +$12.7M
MDLZ icon
149
Mondelez International
MDLZ
$80.2B
$72M 0.17%
1,682,863
+72,541
+5% +$3.05M
KR icon
150
Kroger
KR
$36.3B
$71.5M 0.17%
2,605,386
-203,837
-7% -$4.75M

Similar funds

Guggenheim Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.

  • Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
  • Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
  • Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
  • Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
  • Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
  • Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.